FDA Announces Collection of Information for Drug Registration and Distribution

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to the registration of drug producers and the listing of drugs in commercial distribution, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.